SCHEMBL597202

SCHEMBL597202

CC(=O)CN[C@H](C(=O)O)C(C)C

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.38
PLA2G2A P14555 1/20 0.37
PLA2G5 P39877 1/20 0.37
ALDH1A1 P00352 6/20 0.35
NPSR1 Q6W5P4 2/20 0.35
GAA P10253 2/20 0.34
MAPT P10636 1/20 0.34
GABRR1 P24046 2/20 0.33
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
POLB P06746 1/20 0.33
CYP1A2 P05177 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
MME P08473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16041452 0.84 ALDH1A1 (0.40) SMN1; SMN2PLA2G2APLA2G5ALDH1A1NPSR1
SCHEMBL16041451 0.84 ALDH1A1 (0.40) SMN1; SMN2PLA2G2APLA2G5ALDH1A1NPSR1
SCHEMBL758494 0.83 SMN1; SMN2 (0.36) SMN1; SMN2PLA2G2APLA2G5ALDH1A1NPSR1
SCHEMBL758495 0.83 SMN1; SMN2 (0.36) SMN1; SMN2PLA2G2APLA2G5ALDH1A1NPSR1
SCHEMBL597622 0.83 ALDH1A1 (0.53) ALDH1A1MAPK1MME
SCHEMBL5074809 0.81 SMN1; SMN2 (0.40) SMN1; SMN2PLA2G2APLA2G5ALDH1A1NPSR1
SCHEMBL5074810 0.81 SMN1; SMN2 (0.40) SMN1; SMN2PLA2G2APLA2G5ALDH1A1NPSR1
SCHEMBL7401675 0.78 PLA2G2A (0.39) SMN1; SMN2PLA2G2APLA2G5ALDH1A1NPSR1
SCHEMBL4622349 0.78 SMN1; SMN2 (0.46) SMN1; SMN2PLA2G2APLA2G5ALDH1A1NPSR1
SCHEMBL2551055 0.78 NPSR1 (0.44) SMN1; SMN2PLA2G2APLA2G5ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180338936-A1 Methods and Compositions for the Treatment and Prevention of Allergic Rhinitis MARTIN ALAIN (US) 2018-11-29 US claimed
US-9675569-B2 Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells CELLULAR SCIENCES, INC. 2017-06-13 US claimed
US-20160022616-A1 Method for Treating a Pulmonary Disease State in Mammals by Up Regulating Indigenous in vivo Levels of Inflammatory Agents in Mammalian Cells CELLULAR SCIENCES, INC. 2016-01-28 US claimed
WO-2013187891-A1 METHOD FOR TREATING A PULMONARY DISEASE STATE IN MAMMALS BY UP REGULATING INDIGENOUS IN VIVO LEVELS OF INFLAMMATORY AGENTS IN MAMMALIAN CELLS MARTIN ALAIN (US) 2013-12-19 WO claimed
US-8211943-B2 Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells CELLULAR SCIENCES, INC. 2012-07-03 US claimed
US-8114907-B2 Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells CELLULAR SCIENCES INC (US) 2012-02-14 US claimed
EP-1183022-B1 METHOD AND COMPOSITION FOR TREATING MAMMALIAN NASAL AND SINUS DISEASES CAUSED BY INFLAMMATORY RESPONSE CELLULAR SCIENCES INC (US) 2010-12-29 EP claimed
EP-2187738-A1 METHOD FOR TREATING A PULMONARY DISEASE STATE IN MAMMALS BY UP OR DOWN REGULATING INDIGENOUS IN VIVO LEVELS OF INFLAMMATORY AGENTS IN MAMMALIAN CELLS Cellular Sciences, Inc. (US) 2010-05-26 EP claimed
US-20090041738-A1 Method for treating a pulmonary disease state in mammals by up or down regulating indigenous in vivo levels of inflammatory agents in mammalian cells CELLULAR SCIENCES, INC. 2009-02-12 US claimed
US-20090041739-A1 Method for treating a pulmonary disease state in mammals by up or down regulating indigenous in vivo levels of inflammatory agents in mammalian cells CELLULAR SCIENCES, INC. 2009-02-12 US claimed
WO-1998004254-A1 COMPOSITION OF PYRUVATE AND PROTEIN AND METHOD FOR INCREASING PROTEIN CONCENTRATION IN A MAMMAL BEALE PAXTON K (US) 1998-02-05 WO claimed
WO-1998004253-A1 COMPOSITION OF PYRUVATE AND ANTI-CORTISOL COMPOUNDS AND METHOD FOR INCREASING PROTEIN CONCENTRATION IN A MAMMAL BEALE PAXTON K (US) 1998-02-05 WO claimed
EP-0804181-A1 METHOD AND COMPOSITION FOR TREATING MAMMALIAN DISEASES CAUSED BY INFLAMMATORY RESPONSE Cellular Sciences, Inc. (US) 1997-11-05 EP claimed
WO-1997010818-A1 METHOD AND COMPOSITION FOR TREATING MAMMALIAN DISEASES CAUSED BY INFLAMMATORY RESPONSE CELLULAR SCIENCES, INC. (US) 1997-03-27 WO claimed
US-5472980-A Reducing insulin resistance in mammals with amino acid derivatives ABBOTT LABORATORIES (US) 1995-12-05 US claimed
EP-0636117-A4 METHOD OF ADMINISTERING PYRUVATE AND METHODS OF SYNTHESIZING PYRUVATE PRECURSORS. ABBOTT LAB (US) 1995-07-26 EP claimed
EP-0636117-A1 USE OF PYRUVAMIDE AND SELECTED PYRUVYL-AMINO ACIDS ABBOTT LABORATORIES (US) 1995-02-01 EP claimed
US-5283260-A Oral ingesting a pyruvyl-amino acid compound before a glucose tolerance test ABBOTT LABORATORIES (US) 1994-02-01 US claimed
WO-1993021147-A1 METHOD OF ADMINISTERING PYRUVATE AND METHODS OF SYNTHESIZING PYRUVATE PRECURSORS ABBOTT LABORATORIES (US) 1993-10-28 WO claimed
US-5256697-A Covalently linked pyruvyl-amino compound ABBOTT LABORATORIES 1993-10-26 US claimed